Literature DB >> 25363281

Overcoming concealment effects of targeting moieties in the PEG corona: controlled permeable polymersomes decorated with folate-antennae for selective targeting of tumor cells.

Mohamed A Yassin1, Dietmar Appelhans, Ralf Wiedemuth, Petr Formanek, Susanne Boye, Albena Lederer, Achim Temme, Brigitte Voit.   

Abstract

In the context of diligent efforts to improve the tumor targeting efficiency of drug carriers, a shape-persistent polymersome which possess a pH-tunable membrane as well as folate targeting antennae is reported. The membrane of such polymersomes behaves as gate which undergoes "on" and "off" switches in response to pH stimuli. Thus, polymersomes can effectively prohibit the premature release of chemotherapeutic agents such as doxorubicin in physiological conditions, but promote drug release once they are triggered in the acidified endosomal compartment. Importantly, the folate moieties are installed on the surface of polymersomes as protruding antennae by doping the polymersomes with folate-terminated block copolymers designed to have longer PEG segments. Thereby, the folate moieties are freed from concealment and steric effects exerted by the dense PEG corona. The cellular uptake of the FA-antennae polymersomes by tumor cells is significantly enhanced facilitated by the freely accessible folate antennae; however, the normal cells record a low level of cellular uptake due to the stealth property of the PEG corona. Overall, the excellent biocompatibility, controlled permeability, targeted internalization, as well as selective cytotoxicity of such polymersomes set up the basis for properly smart carrier for targeted drug delivery.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  concealment effect; doxorubicin; drug delivery; polymersomes; tumor targeting

Mesh:

Substances:

Year:  2014        PMID: 25363281     DOI: 10.1002/smll.201402581

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  8 in total

Review 1.  Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery.

Authors:  Ruslan G Tuguntaev; Chukwunweike Ikechukwu Okeke; Jing Xu; Chan Li; Paul C Wang; Xing-Jie Liang
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

2.  Photo-Cross-Linked Dual-Responsive Hollow Capsules Mimicking Cell Membrane for Controllable Cargo Post-Encapsulation and Release.

Authors:  Xiaoling Liu; Dietmar Appelhans; Qiang Wei; Brigitte Voit
Journal:  Adv Sci (Weinh)       Date:  2016-12-12       Impact factor: 16.806

3.  Antibody-Functionalized Carnauba Wax Nanoparticles to Target Breast Cancer Cells.

Authors:  Banu Iyisan; Johanna Simon; Yuri Avlasevich; Stanislav Baluschev; Volker Mailaender; Katharina Landfester
Journal:  ACS Appl Bio Mater       Date:  2022-01-03

4.  Reconstitution properties of biologically active polymersomes after cryogenic freezing and a freeze-drying process.

Authors:  Robert Ccorahua; Silvia Moreno; Hannes Gumz; Karin Sahre; Brigitte Voit; Dietmar Appelhans
Journal:  RSC Adv       Date:  2018-07-17       Impact factor: 3.361

5.  Redox-Responsive Polymersomes as Smart Doxorubicin Delivery Systems.

Authors:  Carmen Ferrero; Marta Casas; Isidoro Caraballo
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

6.  Artificial Organelles with Orthogonal-Responsive Membranes for Protocell Systems: Probing the Intrinsic and Sequential Docking and Diffusion of Cargo into Two Coexisting Avidin-Polymersomes.

Authors:  Xueyi Wang; Silvia Moreno; Susanne Boye; Peng Wang; Xiaoling Liu; Albena Lederer; Brigitte Voit; Dietmar Appelhans
Journal:  Adv Sci (Weinh)       Date:  2021-04-07       Impact factor: 16.806

7.  Fluorescent Magnetopolymersomes: A Theranostic Platform to Track Intracellular Delivery.

Authors:  Oliver Bixner; Noga Gal; Christoph Zaba; Andrea Scheberl; Erik Reimhult
Journal:  Materials (Basel)       Date:  2017-11-13       Impact factor: 3.623

8.  Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile.

Authors:  Wenqun Li; Junyong Wu; Jiang Zhang; Jingjing Wang; Daxiong Xiang; Shilin Luo; Jianhe Li; Xinyi Liu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.